FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Prins

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Robert M Kwee; Bé J Meems; Werner H Mess; Martin H Prins; Johannes W M Ter Berg; Rob J van der Geest; Jos M A van Engelshoven; Robert J van Oostenbrugge; Joachim E Wildberger; Cees L Franke; Arthur G G C Korten; M Eline Kooi
MRI of carotid atherosclerosis to identify TIA and stroke patients who are at risk of a recurrence.
Karolina Szerencsi; Ludovic van Amelsvoort; Wolfgang Viechtbauer; Danielle C L Mohren; Martin H Prins; IJmert Kant
The association between study characteristics and outcome in the relation between job stress and cardiovascular disease - a multilevel meta-regression analysis.
Alex KleinJan; Martin H Prins; F F van Doormaal; Harry R Büller; J M M B Otten
Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Prins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Robert M Kwee; Bé J Meems; Werner H Mess; Martin H Prins; Johannes W M Ter Berg; Rob J van der Geest; Jos M A van Engelshoven; Robert J van Oostenbrugge; Joachim E Wildberger; Cees L Franke; Arthur G G C Korten; M Eline Kooi
MRI of carotid atherosclerosis to identify TIA and stroke patients who are at risk of a recurrence.
Journal of magnetic resonance imaging : JMRI 2013;37(5):1189-94.
2012: Karolina Szerencsi; Ludovic van Amelsvoort; Wolfgang Viechtbauer; Danielle C L Mohren; Martin H Prins; IJmert Kant
The association between study characteristics and outcome in the relation between job stress and cardiovascular disease - a multilevel meta-regression analysis.
Scandinavian journal of work, environment & health 2012;38(6):489-502.
2012: Alex KleinJan; Martin H Prins; F F van Doormaal; Harry R Büller; J M M B Otten
Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism.
The Netherlands journal of medicine 2012;70(7):311-7.
2012: Patrick Houthuizen; Jolanda Kluin; Jos G Maessen; Thomas T Poels; Martin H Prins; Jan Baan; Mohamed Bentala; Guus R G Brueren; Ricardo Cocchieri; Peter de Jaegere; Peter den Heijer; Martin J Schalij; Pieter R Stella; Ben M Swinkels; Jurriën M ten Berg; Robert M A van der Boon; Frank van der Kley; Leen A F M Van Garsse; Vincent Van Ommen; Albert H M van Straten; Frits W Prinzen
Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death.
Circulation 2012;126(6):720-8.
2012: Roel J J van de Laar; Martin H Prins; Coen D A Stehouwer; Saskia J te Velde; Jos W R Twisk; Bas C T van Bussel; Isabel Ferreira
Lower lifetime dietary fiber intake is associated with carotid artery stiffness: the Amsterdam Growth and Health Longitudinal Study.
The American journal of clinical nutrition 2012;96(1):14-23.
2012: Paolo Prandoni; Martin H Prins; Maria Teresa Sartori; Maria C Ugolotti; Maria R Veropalumbo; Alessia Bracco; Angelo Ghirarduzzi; Franco Noventa; Vittorio Pengo; Anthonie W A Lensing
Family history of venous thrombosis or sudden death as a risk factor for venous thromboembolism.
Thrombosis and haemostasis 2012;107(6):1191-2.
2012: Ron Pisters; Martin H Prins; A John Camm; Harry J G M Crijns; Jean-Yves Le Heuzey; Aldo P Maggioni; Robby Nieuwlaat
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(5):666-74.
2012: A J ten Cate-Hoek; Diane B Toll; E F van der Velde; H C P M van Weert; Harry R Büller; A W Hoes; Manuela A Joore; K G M Moons; Ruud Oudega; Martin H Prins; Henri ('Jelle') Stoffers
Common alternative diagnoses in general practice when deep venous thrombosis is excluded.
The Netherlands journal of medicine 2012;70(3):130-5.
2012: Paul J G Ernest; Fred Hendrikse; Martin H Prins; Jan S A G Schouten; Henny J M Beckers; Carroll A B Webers
The evidence base to select a method for assessing glaucomatous visual field progression.
Acta ophthalmologica 2012;90(2):101-8.
2012: Andrea Peeters; Martin H Prins; Jan S A G Schouten; Johan L Severens; Fred Hendrikse; Carroll A B Webers
Latanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.
Acta ophthalmologica 2012;90(2):146-54.
2012: Paolo Prandoni; Martin H Prins; Roberto Quintavalla; S Siragusa; Sabina Villalta; Francesco Astorri; Carlo Bova; Eugenio Bucherini; Benilde Cosmi; Stefano Cuppini; Fabio Dalla Valle; Anthonie W A Lensing; Franco Noventa
Thigh-length versus below-knee compression elastic stockings for prevention of the postthrombotic syndrome in patients with proximal-venous thrombosis: a randomized trial.
Blood 2012;119(6):1561-5.
2012: Johanna W M Nin; Martin H Prins; Casper G Schalkwijk; Coen D A Stehouwer; Nish Chaturvedi; Isabel Ferreira; John H Fuller
Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.
European journal of endocrinology / European Federation of Endocrine Societies 2012;166(2):325-32.
2012: Paul J G Ernest; Fred Hendrikse; Martin H Prins; Jan S A G Schouten; Wolfgang Viechtbauer; Henny J M Beckers; Carroll A B Webers
The influence of the assessment method on the incidence of visual field progression in glaucoma: a network meta-analysis.
Acta ophthalmologica 2012;90(1):10-9.
2012: Harry R Büller; Alex S Gallus; Gerard Pillion; Martin H Prins; Gary E Raskob
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial.
Lancet 2012;379(9811):123-9.
2012: Marianne Eijkemans; Monique Mommers; Jos M Th Draaisma; Carel Thijs; Martin H Prins
Physical activity and asthma: a systematic review and meta-analysis.
PloS one 2012;7(12):e50775.
2012: Petra M G Erkens; Harry R Büller; Hugo ten Cate; Martin H Prins
Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis.
PloS one 2012;7(9):e42269.
2012: Geert-Jan Geersing; Arno W Hoes; Wim A M Lucassen; Karel G M Moons; Ruud Oudega; Martin H Prins; Harry R Büller; Hugo ten Cate; Petra M G Erkens; Henk C P M van Weert; Henri ('Jelle') Stoffers
Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study.
BMJ (Clinical research ed.) 2012;345():e6564.
2012: Robert M Kwee; Werner H Mess; Martin H Prins; Martine T B Truijman; Robert J van Oostenbrugge; Joachim E Wildberger; Cees L Franke; Arthur G G C Korten; M Eline Kooi
Longitudinal MRI study on the natural history of carotid artery plaques in symptomatic patients.
PloS one 2012;7(7):e42472.
2011: Elizabeth F W van Vlijmen; Nic J G M Veeger; Harry R Büller; Karly Hamulyák; Saskia Middeldorp; Martin H Prins; Karina Meijer
Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception.
Blood 2011;118(8):2055-61; quiz 2375.
2011: Theodore E Warkentin; Harry R Büller; Bruce L Davidson; Alexander Gallus; Michael Gent; Anthonie W A Lensing; Franco Piovella; Martin H Prins; A E M Segers; John G Kelton
Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
Chest 2011;140(2):366-73.
2011: M Smid; A W J H Dielis; M Winkens; Henri M H Spronk; René Van Oerle; Karly Hamulyák; Martin H Prins; Jan Rosing; J L Waltenberger; Hugo ten Cate
Thrombin generation in patients with a first acute myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2011;9(3):450-6.
2011: Roel J van de Laar; Isabel Ferreira; Willem van Mechelen; Martin H Prins; Jos W Twisk; Coen D Stehouwer
Habitual physical activity and peripheral arterial compliance in young adults: the Amsterdam growth and health longitudinal study.
American journal of hypertension 2011;24(2):200-8.
2011: S Roshani; W M Lijfering; Michiel Coppens; Karly Hamulyák; Martin H Prins; Harry R Büller; Saskia Middeldorp
Risk factors of arterial cardiovascular complications in patients with prior venous thromboembolism.
The Netherlands journal of medicine 2011;69(1):27-30.
2011: Eit Frits van der Velde; Diane B Toll; Arina J Ten Cate-Hoek; Ruud Oudega; Henri ('Jelle') Stoffers; Patrick M Bossuyt; Harry R Büller; Martin H Prins; Arno W Hoes; Karel G M Moons; Henk C P M van Weert
Comparing the diagnostic performance of 2 clinical decision rules to rule out deep vein thrombosis in primary care patients.
Annals of family medicine 2011;9(1):31-6.
2011: Andrea Peeters; Carroll A B Webers; Martin H Prins; fred hendrikse; Jan S A G Schouten
The clinical impact of 2 different strategies for initiating therapy in patients with ocular hypertension.
Journal of glaucoma 2011;20(1):30-6.
2011: F F Van Doormaal; W Terpstra; René van der Griend; Martin H Prins; Marten Nijziel; Marcel A van de Ree; Harry R Büller; J C Dutilh; A ten Cate-Hoek; S M Van Den Heiligenberg; Jan van der Meer; J M Otten
Is extensive screening for cancer in idiopathic venous thromboembolism warranted?
Journal of thrombosis and haemostasis : JTH 2011;9(1):79-84.
2011: Kristel J M Janssen; Eit F van der Velde; Arina J Ten Cate; Martin H Prins; Henk C P M van Weert; Henri ('Jelle') Stoffers; Harry R Büller; Ruud Oudega; Arno Hoes; Diane B Toll; Karel G M Moons
Optimisation of the diagnostic strategy for suspected deep-vein thrombosis in primary care.
Thrombosis and haemostasis 2011;105(1):154-60.
2010: Brigitte A B Essers; Carmen D Dirksen; Martin H Prins; H A M Neumann
Assessing the public's preference for surgical treatment of primary basal cell carcinoma: a discrete-choice experiment in the south of the Netherlands.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2010;36(12):1950-5.
2010: Esther R van Bladel; Mariëtte J Agterof; Bernard D Frijling; René van der Griend; Martin H Prins; Roger Schutgens; Douwe H Biesma
Out of hospital anticoagulant therapy in patients with acute pulmonary embolism is frequently practised but not perfect.
Thrombosis research 2010;126(6):481-5.
2010: Frederiek F van Doormaal; Alexander T Cohen; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; Harry R Büller
Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.
Thrombosis and haemostasis 2010;104(1):86-91.
2010: Robert M Kwee; Robert J van Oostenbrugge; Martin H Prins; Johannes W M Ter Berg; Cees L Franke; Arthur G G C Korten; Bé J Meems; Jos M A van Engelshoven; Joachim E Wildberger; Werner H Mess; M Eline Kooi
Symptomatic patients with mild and moderate carotid stenosis: plaque features at MRI and association with cardiovascular risk factors and statin use.
Stroke; a journal of cerebral circulation 2010;41(7):1389-93.
2010: Arina J Ten Cate-Hoek; Hugo ten Cate; Jan Tordoir; Karly Hamulyák; Martin H Prins
Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome.
Journal of vascular surgery 2010;52(1):132-8.
2010: M J Agterof; Roger Schutgens; Repke J Snijder; G Epping; H G Peltenburg; E F M Posthuma; J A Hardeman; René van der Griend; T Koster; Martin H Prins; Douwe H Biesma
Out of hospital treatment of acute pulmonary embolism in patients with a low NT-proBNP level.
Journal of thrombosis and haemostasis : JTH 2010;8(6):1235-41.
2010: Anja B U Mäkelburg; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Willem M Lijfering
Different risk of deep vein thrombosis and pulmonary embolism in carriers with factor V Leiden compared with non-carriers, but not in other thrombophilic defects. Results from a large retrospective family cohort study.
Haematologica 2010;95(6):1030-3.
2010: Willem M Lijfering; Saskia Middeldorp; Nic J G M Veeger; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Circulation 2010;121(15):1706-12.
2010: Bengt I Eriksson; A G G Turpie; Michael R Lassen; Martin H Prins; Giancarlo Agnelli; Peter Kälebo; G Wetherill; J W Wilpshaar; L Meems
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2).
Journal of thrombosis and haemostasis : JTH 2010;8(4):714-21.
2010: M M J Beckers; Henk Ruven; C A Seldenrijk; Martin H Prins; D H Biesma
Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Thrombosis research 2010;125(4):318-21.
2010: Andrea Peeters; Carroll A B Webers; Martin H Prins; Maurice Zeegers; fred hendrikse; Jan S A G Schouten
Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma.
Acta ophthalmologica 2010;88(1):5-11.
2010: Petra Mg Erkens; Martin H Prins
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
Cochrane database of systematic reviews (Online) 2010;(9):CD001100.
2010: Brigitte A B Essers; Debby van Helvoort-Postulart; Martin H Prins; Martino Neumann; Carmen D Dirksen
Does the inclusion of a cost attribute result in different preferences for the surgical treatment of primary basal cell carcinoma?: a comparison of two discrete-choice experiments.
PharmacoEconomics 2010;28(6):507-20.
2009: Rikkert van der Valk; Carroll A B Webers; Thomas Lumley; fred hendrikse; Martin H Prins; Jan S A G Schouten
A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure.
Journal of clinical epidemiology 2009;62(12):1279-83.
2009: Mariette J Agterof; Esther R van Bladel; Roger Schutgens; Repke J Snijder; Ellen A M Tromp; Martin H Prins; Douwe H Biesma
Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration.
Thrombosis and haemostasis 2009;102(4):683-7.
2009: Willem M Lijfering; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families.
Blood 2009;114(10):2031-6.
2009: Willem M Lijfering; Jan-Leendert Brouwer; Nic J G M Veeger; Ivan Bank; Michiel Coppens; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.
Blood 2009;113(21):5314-22.
2009: Paolo Prandoni; Martin H Prins; Anthonie W A Lensing; Angelo Ghirarduzzi; Walter Ageno; matteo giorgi pierfranceschi; GL Scannapieco; GB Ambrosio; Raffaele Pesavento; Stefano Cuppini; Roberto Quintavalla; Giancarlo Agnelli
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial.
Annals of internal medicine 2009;150(9):577-85.
2009: C B De Vos; B Weijs; H J G M Crijns; Emile C Cheriex; A Palmans; J Habets; Martin H Prins; R Pisters; Robby Nieuwlaat; Robert G Tieleman
Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation.
Heart (British Cardiac Society) 2009;95(10):835-40.
2009: Frederiek F van Doormaal; Gary E Raskob; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Anthonie W A Lensing; Franco Piovella; Martin H Prins; Harry R Büller
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Thrombosis and haemostasis 2009;101(4):762-9.
2009: Harry R Büller; Arina J Ten Cate-Hoek; Arno Hoes; Manuela A Joore; Karel Moons; Ruud Oudega; Martin H Prins; Henri ('Jelle') Stoffers; Diane B Toll; Eit F van der Velde; Henk C P M van Weert
Safely ruling out deep venous thrombosis in primary care.
Annals of internal medicine 2009;150(4):229-35.
2009: Martin H Prins; I Guillemin; H Gilet; S Gabriel; B Essers; G Raskob; S R Kahn
Scoring and psychometric validation of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).
Health and quality of life outcomes 2009;7():30.
2009: Simone J S Sep; Luc J M Smits; Martin H Prins; Marc E A Spaanderman; Louis L H Peeters
Simple prepregnant prediction rule for recurrent early-onset hypertensive disease in pregnancy.
Reproductive sciences (Thousand Oaks, Calif.) 2009;16(1):80-7.
2009: Anja B U Mäkelburg; Willem M Lijfering; Saskia Middeldorp; Karly Hamulyák; Nic J G M Veeger; Martin H Prins; Harry R Büller; Jan van der Meer
Low absolute risk of venous and arterial thrombosis in hyperhomocysteinaemia - a prospective family cohort study in asymptomatic subjects.
Thrombosis and haemostasis 2009;101(1):209-12.
2009: Nienke Folkeringa; Fleurisca J Korteweg; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyak; Martin H Prins; Jan Jaap H M Erwich; Harry R Büller; Jan van der Meer
Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study.
Thrombosis research 2009;123(3):511-4.
2008: Mathilde Nijkeuter; Lidwine W Tick; Maaike Sohne; Marieke J H A Kruip; Harry R Buller; Frank W G Leebeek; Mark H H Kramer; Frederikus A Klok; Martin H Prins; Menno V Huisman
Excluding pulmonary embolism without imaging tests--can our diagnostic algorithm be optimized?
Thrombosis and haemostasis 2008;100(6):1203-6.
2008: Harry R Buller; Anthonie W A Lensing; Martin H Prins; Giancarlo Agnelli; Alexander Cohen; Alexander Gallus; Frank Misselwitz; Gary E Raskob; Sebastian Schellong; A E M Segers
A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Blood 2008;112(6):2242-7.
2008: Henri M H Spronk; Arne W J H Dielis; Erik de Smedt; René Van Oerle; Diane Fens; Martin H Prins; Karly Hamulyák; Hugo ten Cate
Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory.
Thrombosis and haemostasis 2008;100(2):362-4.
2008: Arina J ten Cate-Hoek; Arne W J H Dielis; Henri M H Spronk; René Van Oerle; Karly Hamulyák; Martin H Prins; Hugo ten Cate
Thrombin generation in patients after acute deep-vein thrombosis.
Thrombosis and haemostasis 2008;100(2):240-5.
2008: Kim M Smits; Luc Smits; Frenk Peeters; Jan S A G Schouten; Rob G J H Janssen; H J M Smeets; Jim van Os; Martin H Prins
The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients.
Psychiatric genetics 2008;18(4):184-90.
2008: Nienke Folkeringa; Michiel Coppens; Nic J G M Veeger; Victor J J Bom; Saskia Middeldorp; Karly Hamulyak; Martin H Prins; Harry R Büller; Jan van der Meer
Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.
Thrombosis and haemostasis 2008;100(1):38-44.
2008: Rikkert van der Valk; Carroll A B Webers; fred hendrikse; Stefan C de Vogel; Martin H Prins; Jan S A G Schouten
Predicting intraocular pressure change before initiating therapy: timolol versus latanoprost.
Acta ophthalmologica 2008;86(4):415-8.
2008: Robby Nieuwlaat; Martin H Prins; Jean-Yves Le Heuzey; Panos E Vardas; Etienne Aliot; Massimo Santini; Stuart M Cobbe; Jos W M G Widdershoven; Leo H Baur; Samuel Lévy; Harry J G M Crijns
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation.
European heart journal 2008;29(9):1181-9.
2008: A Peeters; Jan S A G Schouten; Carroll A B Webers; Martin H Prins; fred hendrikse; Johan L Severens
Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
Eye (London, England) 2008;22(3):354-62.
2008: Willem M Lijfering; Michiel Coppens; Nic J G M Veeger; Saskia Middeldorp; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Hyperhomocysteinemia is not a risk factor for venous and arterial thrombosis, and is associated with elevated factor VIII levels.
Thrombosis research 2008;123(2):244-50.
2008: Arina J ten Cate-Hoek; Martin H Prins
Low molecular weight heparins in cancer. Management and prevention of venous thromboembolism in patients with malignancies.
Thrombosis research 2008;122(5):584-98.
2007: Ivan Bank; Marlène H W van de Poel; Michiel Coppens; Karly Hamulyák; Martin H Prins; Jan van der Meer; Nic J G M Veeger; Harry R Büller; Saskia Middeldorp
Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
Thrombosis and haemostasis 2007;98(5):1040-4.
2007: Harry R Buller; Ander T Cohen; Bruce Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Gerard Pillion; Franco Piovella; Martin H Prins; Gary E Raskob
Extended prophylaxis of venous thromboembolism with idraparinux.
The New England journal of medicine 2007;357(11):1105-12.
2007: Harry R Buller; Ander T Cohen; Bruce Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Gerard Pillion; Franco Piovella; Martin H Prins; Gary E Raskob
Idraparinux versus standard therapy for venous thromboembolic disease.
The New England journal of medicine 2007;357(11):1094-104.
2007: Willem M Lijfering; Michiel Coppens; Marlène H W van de Poel; Saskia Middeldorp; Karly Hamulyák; Ivan Bank; Nic J G M Veeger; Martin H Prins; Harry R Büller; Jan van der Meer
The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defects.
Thrombosis and haemostasis 2007;98(2):457-63.
2007: Bengt I Eriksson; Alexander G G Turpie; Michael R Lassen; Martin H Prins; Giancarlo Agnelli; Peter Kälebo; M L Gaillard; L Meems
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery.
Journal of thrombosis and haemostasis : JTH 2007;5(8):1660-5.
2007: Antonio Marchiori; Laura Mosena; Martin H Prins; Paolo Prandoni
The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Haematologica 2007;92(8):1107-14.
2007: Paolo Prandoni; Barbara A Hutten; Carlo J J van Dongen; R Pesavento; Martin H Prins
Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1555.
2007: Michiel Coppens; Nienke Folkeringa; M J Teune; Karly Hamulyák; Jan van der Meer; Martin H Prins; Harry R Büller; Saskia Middeldorp
Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1444-8.
2007: Mathilde Nijkeuter; Hanneke Kwakkel-van Erp; Maaike Söhne; Lidwine W Tick; Marieke J H A Kruip; Eric F Ullmann; Mark H H Kramer; Harry R Büller; Martin H Prins; Frank W G Leebeek; Menno V Huisman
Clinically suspected acute recurrent pulmonary embolism: a diagnostic challenge.
Thrombosis and haemostasis 2007;97(6):944-8.
2007: Robby Nieuwlaat; S Bertil Olsson; Gregory Y H Lip; A John Camm; Günter Breithardt; Alessandro Capucci; Joan Meeder; Martin H Prins; Samuel Lévy; Harry J G M Crijns
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
American heart journal 2007;153(6):1006-12.
2007: Bruce L Davidson; Harry R Büller; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; A E M Segers; Anthonie W A Lensing
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
Journal of thrombosis and haemostasis : JTH 2007;5(6):1191-4.
2007: Kim M Smits; Luc Smits; Jan S A G Schouten; Frenk Peeters; Martin H Prins
Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Clinical therapeutics 2007;29(4):691-702.
2007: Gwenn E C Wetzels; Patricia J Nelemans; Jan S A G Schouten; Carmen D Dirksen; Trudy van der Weijden; Henri ('Jelle') Stoffers; Robert Janknegt; Peter W de Leeuw; Martin H Prins
Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial.
American journal of hypertension 2007;20(2):119-25.
2007: Martin H Prins; Kim M Smits; Luc Smits
Methodologic ramifications of paying attention to sex and gender differences in clinical research.
Gender medicine 2007;4 Suppl B():S106-10.
2007: Daniëlle E M Brunenberg; Gwenn E C Wetzels; Patricia J Nelemans; Carmen D Dirksen; Johan L Severens; Henri ('Jelle') Stoffers; Jan S A G Schouten; Martin H Prins; Peter W de Leeuw; Manuela A Joore
Cost effectiveness of an adherence-improving programme in hypertensive patients.
PharmacoEconomics 2007;25(3):239-51.
2007: T Dinh; Robby Nieuwlaat; Robert G Tieleman; H R Büller; N A Mensing van Charante; Martin H Prins; Harry J G M Crijns
Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey.
International journal of clinical practice 2007;61(1):24-31.
2007: Carroll A B Webers; Rikkert van der Valk; Jan S A G Schouten; Maurice Zeegers; Martin H Prins; fred hendrikse
Intraocular pressure-lowering effect of adding dorzolamide or latanoprost to timolol: a meta-analysis of randomized clinical trials.
Ophthalmology 2007;114(1):40-6.
2006: Robby Nieuwlaat; Alessandro Capucci; Gregory Y H Lip; S Bertil Olsson; Martin H Prins; Fred H M Nieman; José López-Sendón; Panos E Vardas; Etienne Aliot; Massimo Santini; Harry J G M Crijns
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
European heart journal 2006;27(24):3018-26.
2006: Marieke J H A Kruip; Maaike Söhne; Mathilde Nijkeuter; H M Kwakkel-Van Erp; Lidwine W Tick; S J M Halkes; Martin H Prins; Mark H H Kramer; Menno V Huisman; Harry R Büller; Frank W G Leebeek
A simple diagnostic strategy in hospitalized patients with clinically suspected pulmonary embolism.
Journal of internal medicine 2006;260(5):459-66.
2006: Michiel Coppens; Marlène H W van de Poel; Ivan Bank; Karly Hamulyak; Jan van der Meer; Nic J G M Veeger; Martin H Prins; Harry R Buller; Saskia Middeldorp
A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin 20210A mutation.
Blood 2006;108(8):2604-7.
2006: Rikkert van der Valk; Jan S A G Schouten; Carroll A B Webers; fred hendrikse; Martin H Prins
Changes in glaucoma treatment and achieved IOP after introduction of new glaucoma medication.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2006;244(10):1267-72.
2006: Paolo Prandoni; Angelo Ghirarduzzi; Martin H Prins; Vittorio Pengo; B L Davidson; H Sørensen; Raffaele Pesavento; M Iotti; E Casiglia; Sabino Iliceto; Antonio Pagnan; Anthonie W A Lensing
Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis.
Journal of thrombosis and haemostasis : JTH 2006;4(9):1891-6.
2006: Ghislaine A P G van Mastrigt; Jos G Maessen; John Heijmans; Johan L Severens; Martin H Prins
Does fast-track treatment lead to a decrease of intensive care unit and hospital length of stay in coronary artery bypass patients? A meta-regression of randomized clinical trials.
Critical care medicine 2006;34(6):1624-34.
2006: Jan Van Zundert; Donal Harney; Elbert A J Joosten; Marcel E Durieux; Jacob Patijn; Martin H Prins; Maarten van Kleef
The role of the dorsal root ganglion in cervical radicular pain: diagnosis, pathophysiology, and rationale for treatment.
Regional anesthesia and pain medicine 2006;31(2):152-67.
2006: P L J van der Heiden; Martin H Prins; Wouter de Monyé; Marco L J van Strijen; Jan Dirk Banga; Piet E Postmus; Marije ten Wolde; Harry R Büller; D P M Brandjes; Menno V Huisman
Pulmonary embolism as a first clinical sign of occult malignancy: a prospective follow-up study.
Thrombosis and haemostasis 2006;95(3):584-5.
2006: Alexander T Cohen; Bruce L Davidson; Alexander Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.
BMJ (Clinical research ed.) 2006;332(7537):325-9.
2006: Brigitte A B Essers; Carmen D Dirksen; Fred H M Nieman; Nicole W J Smeets; G A M Krekels; Martin H Prins; H A M Neumann
Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
Archives of dermatology 2006;142(2):187-94.
2006: Brigitte A B Essers; Fred H M Nieman; Martin H Prins; G A M Krekels; Nicole W J Smeets; H A M Neumann
Determinants of satisfaction with the health state of the facial skin in patients undergoing surgery for facial basal cell carcinoma.
Patient education and counseling 2006;60(2):179-86.
2006: Arne van Belle; Harry R Büller; Menno V Huisman; Peter M Huisman; Karin A H Kaasjager; Pieter W Kamphuisen; Mark H H Kramer; Marieke J H A Kruip; Johanna M Kwakkel-van Erp; Frank W G Leebeek; Mathilde Nijkeuter; Martin H Prins; Maaike Sohne; Lidwine W Tick
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
JAMA : the journal of the American Medical Association 2006;295(2):172-9.
2006: Robby Nieuwlaat; Mattie Lenzen; Harry J G M Crijns; Martin H Prins; Wilma J M Scholte op Reimer; A Battler; D Hasdai; N Danchin; A K Gitt; Maarten L Simoons; E Boersma
Which factors are associated with the application of reperfusion therapy in ST-elevation acute coronary syndromes?. Lessons from the Euro Heart Survey on Acute Coronary Syndromes I.
Cardiology 2006;106(3):137-46.
2006: Gwenn E C Wetzels; Patricia J Nelemans; Jan S A G Schouten; Boris L G Van Wijk; Martin H Prins
All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions--an observational study.
BMC health services research 2006;6():8.
2005: Marcello Di Nisio; Hans-Martin Otten; Andrea Piccioli; Anthonie W A Lensing; Paolo Prandoni; Harry R Büller; Martin H Prins
Decision analysis for cancer screening in idiopathic venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2391-6.
2005: Robby Nieuwlaat; Alessandro Capucci; A John Camm; S Bertil Olsson; Dietrich Andresen; D Wyn Davies; Stuart M Cobbe; Günter Breithardt; Jean-Yves Le Heuzey; Martin H Prins; Samuel Lévy; Harry J G M Crijns
Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation.
European heart journal 2005;26(22):2422-34.
2005: Dinanda N Kolbach; H A M Neumann; Martin H Prins
Definition of the post-thrombotic syndrome, differences between existing classifications.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2005;30(4):404-14.
2005: Kim M Smits; Jan S A G Schouten; Luc Smits; Foekje F Stelma; Patricia J Nelemans; Martin H Prins
A review on the design and reporting of studies on drug-gene interaction.
Journal of clinical epidemiology 2005;58(7):651-4.
2005: Rikkert van der Valk; Carroll A B Webers; Jan S A G Schouten; Maurice Zeegers; fred hendrikse; Martin H Prins
Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.
Ophthalmology 2005;112(7):1177-85.
2005: Rikkert van der Valk; Jan S A G Schouten; Carroll A B Webers; Henny J M Beckers; Ludovic van Amelsvoort; Hubert J A Schouten; fred hendrikse; Martin H Prins
The impact of a nationwide introduction of new drugs and a treatment protocol for glaucoma on the number of glaucoma surgeries.
Journal of glaucoma 2005;14(3):239-42.
2005: A E M Segers; Martin H Prins; Anthonie W A Lensing; Harry R Buller
Is contrast venography a valid surrogate outcome measure in venous thromboembolism prevention studies?
Journal of thrombosis and haemostasis : JTH 2005;3(5):1099-102.
2005: Carlo J J van Dongen; Paolo Prandoni; Michela Frulla; Antonio Marchiori; Martin H Prins; Barbara A Hutten
Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome.
Journal of thrombosis and haemostasis : JTH 2005;3(5):939-42.
2005: Eric W G Weber; Robert Slappendel; Martin H Prins; Dick B van der Schaaf; Marcel E Durieux; Danja Strümper
Perioperative blood transfusions and delayed wound healing after hip replacement surgery: effects on duration of hospitalization.
Anesthesia and analgesia 2005;100(5):1416-21, table of contents.
2005: Clara P W Klerk; Susanne M Smorenburg; Hans-Martin Otten; Anthonie W A Lensing; Martin H Prins; Franco Piovella; Paolo Prandoni; Monique M E M Bos; Dick J Richel; Geertjan van Tienhoven; Harry R Büller
The effect of low molecular weight heparin on survival in patients with advanced malignancy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(10):2130-5.
2005: Eduard J Libourel; Ivan Bank; Nic J G M Veeger; Karly Hamulyàk; Saskia Middeldorp; Martin H Prins; Harry R Büller; Jan van der Meer
Protein S type III deficiency is no risk factor for venous and arterial thromboembolism in 168 thrombophilic families: a retrospective study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2005;16(2):135-40.
2005: Angelique C M Jansen; Emily S van Aalst-Cohen; Barbara A Hutten; Harry R Büller; John J P Kastelein; Martin H Prins
Guidelines were developed for data collection from medical records for use in retrospective analyses.
Journal of clinical epidemiology 2005;58(3):269-74.
2005: Carlo J J van Dongen; Melvin R MacGillavry; Martin H Prins
Once versus twice daily LMWH for the initial treatment of venous thromboembolism.
Cochrane database of systematic reviews (Online) 2005;(3):CD003074.
2005: Ivan Bank; Eduard J Libourel; Saskia Middeldorp; Karly Hamulyák; Elisabeth C M van Pampus; Maria M W Koopman; Martin H Prins; Jan van der Meer; Harry R Büller
Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(1):79-84.
2005: Marco J L van Strijen; W De Monye; Gerard J Kieft; Peter M T Pattynama; Martin H Prins; Menno V Huisman
Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism: a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy.
Journal of thrombosis and haemostasis : JTH 2005;3(1):17-25.
2004: Mirjam Locadia; Patrick Bossuyt; Peep F M Stalmeier; Mirjam A G Sprangers; Carlo J J van Dongen; Saskia Middeldorp; Ivan Bank; Jan van der Meer; Karly Hamulyák; Martin H Prins
Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences.
Thrombosis and haemostasis 2004;92(6):1336-41.
2004: Mirjam Locadia; Peep F M Stalmeier; Frans J Oort; Martin H Prins; Mirjam A G Sprangers; Patrick Bossuyt
A comparison of 3 valuation methods for temporary health states in patients treated with oral anticoagulants.
Medical decision making : an international journal of the Society for Medical Decision Making 2004;24(6):625-33.
2004: Saskia Middeldorp; Marlène H W van de Poel; Ivan Bank; Karly Hamulyák; Eduard J Libourel; Maria M W Koopman; Martin H Prins; Jan van der Meer; Harry R Büller
Unselected women with elevated levels of factor VIII:C or homocysteine are not at increased risk for obstetric complications.
Thrombosis and haemostasis 2004;92(4):787-90.
2004: Gwenn E C Wetzels; Patricia J Nelemans; Jan S A G Schouten; Martin H Prins
Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review.
Journal of hypertension 2004;22(10):1849-55.
2004: Ivan Bank; Eduard J Libourel; Saskia Middeldorp; Elisabeth C M van Pampus; Maria M W Koopman; Karly Hamulyák; Martin H Prins; Jan van der Meer; Harry R Büller
Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.
Archives of internal medicine 2004;164(17):1932-7.
2004: Harry R Büller; Giancarlo Agnelli; Russel D Hull; Thomas M Hyers; Martin H Prins; Gary E Raskob
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest 2004;126(3 Suppl):401S-428S.
2004: Paolo Prandoni; Enrico Bernardi; Antonio Marchiori; Anthonie W A Lensing; Martin H Prins; Sabina Villalta; Paola Bagatella; Donatella Sartor; Andrea Piccioli; Paolo Simioni; Antonio Pagnan; Antonio Girolami
The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study.
BMJ (Clinical research ed.) 2004;329(7464):484-5.
2004: Paolo Prandoni; Anthonie W A Lensing; Martin H Prins; Michela Frulla; Antonio Marchiori; Enrico Bernardi; Daniela Tormene; Laura Mosena; Antonio Pagnan; Antonio Girolami
Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial.
Annals of internal medicine 2004;141(4):249-56.
2004: Marije ten Wolde; Petronella J Hagen; Melvin R MacGillavry; I J Pollen; Albert T A Mairuhu; Maria M W Koopman; Martin H Prins; Otto S Hoekstra; D P M Brandjes; Pieter E Postmus; Harry R Büller
Non-invasive diagnostic work-up of patients with clinically suspected pulmonary embolism; results of a management study.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1110-7.
2004: Harry R Büller; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; A E M Segers; Roger Cariou; Oscar Leeuwenkamp; Anthonie W A Lensing
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Annals of internal medicine 2004;140(11):867-73.
2004: Andrea Piccioli; Anthonie W A Lensing; Martin H Prins; Anna Falanga; GL Scannapieco; M Ieran; M Cigolini; G B Ambrosio; Manuel Monreal; Antonio Girolami; Paolo Prandoni
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial.
Journal of thrombosis and haemostasis : JTH 2004;2(6):884-9.
2004: Vittorio Pengo; Anthonie W A Lensing; Martin H Prins; Antonio Marchiori; Bruce L Davidson; Francesca Tiozzo; Paolo Albanese; Alessandra Biasiolo; Cinzia Pegoraro; Sabino Iliceto; Paolo Prandoni
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.
The New England journal of medicine 2004;350(22):2257-64.
2004: Arina J ten Cate-Hoek; Martin H Prins
Appropriate level and length of postthrombotic warfarin treatment: an evaluation of recent developments.
Current opinion in hematology 2004;11(3):182-6.
2004: Kim M Smits; Luc Smits; Jan S A G Schouten; Foekje F Stelma; Patricia J Nelemans; Martin H Prins
Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.
Molecular psychiatry 2004;9(5):433-41.
2004: Dinanda N Kolbach; H A M Neumann; Martin H Prins; Karly Hamulyák; J P Cleutjens
Severity of venous insufficiency is related to the density of microvascular deposition of PAI-1, uPA and von Willebrand factor.
VASA. Zeitschrift für Gefässkrankheiten 2004;33(1):19-24.
2004: Mirjam Locadia; Johanna H H van Geest-Daalderop; Mirjam A G Sprangers; Barbara A Hutten; Martin H Prins
The relationship between adherence and quality of treatment with vitamin K antagonists.
Journal of thrombosis and haemostasis : JTH 2004;2(2):362-3.
2004: Hans-Martin Otten; Joost Mathijssen; Hugo ten Cate; Marcel Soesan; Marijke Inghels; Dick J Richel; Martin H Prins
Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
Archives of internal medicine 2004;164(2):190-4.
2004: Lambert J G G Panis; Frank W S M Verheggen; Peter Pop; Martin H Prins
The impact of hospital discharge on inappropriate hospital stay.
International journal of health care quality assurance incorporating Leadership in health services 2004;17(4-5):189-93.
2004: Lambert J G G Panis; Frank W S M Verheggen; Peter Pop; Martin H Prins
Appropriate length of extended day care.
International journal of health care quality assurance incorporating Leadership in health services 2004;17(2-3):81-6.
2004: Dinanda N Kolbach; M W C Sandbrink; Karly Hamulyak; H A M Neumann; Martin H Prins
Non-pharmaceutical measures for prevention of post-thrombotic syndrome.
Cochrane database of systematic reviews (Online) 2004;(1):CD004174.
2004: Eduard J Libourel; Corine P Baljé-Volkers Degrees; Karly Hamulyàk; Martin H Prins; Saskia Middeldorp; Harry R Büller; Jan van der Meer
High factor VIII plasma levels as a risk factor for venous thrombosis: no evidence of inheritance from a family cohort study.
Haematologica 2004;89(1):118-20.
2003: Carlo J J van Dongen; Roel Vink; Barbara A Hutten; Harry R Buller; Martin H Prins
Recurrent thromboembolism after treatment with vitamin K antagonists.
Archives of internal medicine 2003;163(22):2793.
2003: Dinanda N Kolbach; René Van Oerle; Karly Hamulyák; H A M Neumann; Martin H Prins
Local endothelial function and leg symptoms in patients after deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2003;1(12):2679-81.
2003: Afina S Glas; Jeroen G Lijmer; Martin H Prins; Gouke J Bonsel; Patrick Bossuyt
The diagnostic odds ratio: a single indicator of test performance.
Journal of clinical epidemiology 2003;56(11):1129-35.
2003: Harry R Büller; Bruce L Davidson; Hervé Decousus; Alexander Gallus; Michael Gent; Franco Piovella; Martin H Prins; Gary E Raskob; A E M van den Berg-Segers; R Cariou; Oscar Leeuwenkamp; Anthonie W A Lensing
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
The New England journal of medicine 2003;349(18):1695-702.
2003: Martin H Prins; Harry R Büller
When do we need what evidence?
Journal of clinical epidemiology 2003;56(8):709-10.
2003: Carlo J J van Dongen; Martin H Prins; Harry R Büller
Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
The New England journal of medicine 2003;349(4):398-400; author reply 398-400.
2003: Mirjam Locadia; Mirjam A G Sprangers; Hanneke C J M de Haes; Harry R Büller; Martin H Prins
Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis.
Thrombosis and haemostasis 2003;90(1):101-7.
2003: Arno H M Moons; Ron J G Peters; Nick R Bijsterveld; Jan J Piek; Martin H Prins; George P Vlasuk; William E Rote; Harry R Büller
Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.
Journal of the American College of Cardiology 2003;41(12):2147-53.
2003: Marieke J H A Kruip; Monique G L Leclercq; Cees van der Heul; Martin H Prins; Harry R Büller
Diagnostic strategies for excluding pulmonary embolism in clinical outcome studies. A systematic review.
Annals of internal medicine 2003;138(12):941-51.
2003: Carlo J J van Dongen; Roel Vink; Barbara A Hutten; Harry R Büller; Martin H Prins
The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis.
Archives of internal medicine 2003;163(11):1285-93.
2003: Petronella J Hagen; Ieneke J C Hartmann; Otto S Hoekstra; Marcel P M Stokkel; Pieter E Postmus; Martin H Prins
Comparison of observer variability and accuracy of different criteria for lung scan interpretation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):739-44.
2003: Paolo Prandoni; Franca Bilora; Antonio Marchiori; Enrico Bernardi; Francesco Petrobelli; Anthonie W A Lensing; Martin H Prins; Antonio Girolami
An association between atherosclerosis and venous thrombosis.
The New England journal of medicine 2003;348(15):1435-41.
2003: Melvin R Mac Gillavry; Martin H Prins
Oral contraceptives and inherited thrombophilia: a gene-environment interaction with a risk of venous thrombosis?
Seminars in thrombosis and hemostasis 2003;29(2):219-26.
2003: Marco J L van Strijen; Wouter de Monyé; Jan Schiereck; Gerard J Kieft; Martin H Prins; Menno V Huisman; Peter M T Pattynama
Single-detector helical computed tomography as the primary diagnostic test in suspected pulmonary embolism: a multicenter clinical management study of 510 patients.
Annals of internal medicine 2003;138(4):307-14.
2003: Lambert J G G Panis; Marieke Gooskens; Frank W S M Verheggen; Peter Pop; Martin H Prins
Predictors of inappropriate hospital stay: a clinical case study.
International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2003;15(1):57-65.
2003: Dinanda N Kolbach; M W C Sandbrink; H A M Neumann; Martin H Prins
Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome.
Cochrane database of systematic reviews (Online) 2003;(4):CD004177.
2003: D Haverkamp; Barbara A Hutten; Harry R Büller; Alexander Gallus; Anthonie W A Lensing; Martin H Prins
The use of specific antidotes as a response to bleeding complications during anticoagulant therapy for venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2003;1(1):69-73.
2003: Carlo J J van Dongen; M R Mac Gillavry; Martin H Prins
Once versus twice daily LMWH for the initial treatment of venous thromboembolism.
Cochrane database of systematic reviews (Online) 2003;(1):CD003074.
2002: Paolo Prandoni; Anthonie W A Lensing; Martin H Prins; Enrico Bernardi; Antonio Marchiori; Paola Bagatella; Michela Frulla; Laura Mosena; Daniela Tormene; Andrea Piccioli; Paolo Simioni; Antonio Girolami
Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.
Annals of internal medicine 2002;137(12):955-60.
2002: Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.
Blood 2002;100(10):3484-8.
2002: Petronella J Hagen; Ieneke J C Hartmann; Otto S Hoekstra; Marcel P M Stokkel; Gerrit J J Teule; Martin H Prins
How to use a gestalt interpretation for ventilation-perfusion lung scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(10):1317-23.
2002: Eduard J Libourel; Ivan Bank; Johan R Meinardi; Corinne P Baljé -Volkers; Karly Hamulyak; Saskia Middeldorp; Maria M W Koopman; Elisabeth C M van Pampus; Martin H Prins; Harry R Büller; Jan van der Meer
Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Haematologica 2002;87(10):1068-73.
2002: Marije ten Wolde; Roderik A Kraaijenhagen; Martin H Prins; Harry R Büller
The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis.
Archives of internal medicine 2002;162(16):1880-4.
2002: Marjel J van Dam; M Zwart; Femke de Beer; August Smelt; Martin H Prins; Mieke D Trip; Louis M Havekes; Peter J Lansberg; J J P Kastelein
Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia.
Heart (British Cardiac Society) 2002;88(3):234-8.
2002: Roderik A Kraaijenhagen; Franco Piovella; Enrico Bernardi; Fabio Verlato; Erik A M Beckers; Maria M W Koopman; Marisa Barone; Giuseppe Camporese; Bert Jan Potter Van Loon; Martin H Prins; Paolo Prandoni; Harry R Büller
Simplification of the diagnostic management of suspected deep vein thrombosis.
Archives of internal medicine 2002;162(8):907-11.
2002: Johan R Meinardi; Saskia Middeldorp; Pieter J de Kam; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
British journal of haematology 2002;116(3):625-31.
2002: Jeroen F van der Heijden; BA Hutten; Harry R Büller; Martin H Prins
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Cochrane database of systematic reviews (Online) 2002;(1):CD002001.
2002: Martin H Prins; Antonio Marchiori
Risk of recurrent venous thomboembolism--expanding the frontier.
Thrombosis and haemostasis 2002;87(1):1-3.
2001: Johan R Meinardi; Saskia Middeldorp; Pieter J de Kam; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2001;12(8):713-20.
2001: Petronella J Hagen; Marco J L van Strijen; Gerard J Kieft; Y P Graafsma; Martin H Prins; Pieter E Postmus
The application of a Dutch consensus diagnostic strategy for pulmonary embolism in clinical practice.
The Netherlands journal of medicine 2001;59(4):161-9.
2001: Saskia Middeldorp; Johan R Meinardi; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Jan van der Meer; Martin H Prins; Harry R Büller
A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism.
Annals of internal medicine 2001;135(5):322-7.
2001: Hans-Martin Otten; Martin H Prins
Venous thromboembolism and occult malignancy.
Thrombosis research 2001;102(6):V187-94.
2001: Ieneke J C Hartmann; Martin H Prins; Harry R Büller; Jan-Dirk Banga
Acute pulmonary embolism: impact of selection bias in prospective diagnostic studies. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism.
Thrombosis and haemostasis 2001;85(4):604-8.
2001: Ieneke J C Hartmann; Petronella J Hagen; Marcel P M Stokkel; Otto S Hoekstra; Martin H Prins
Technegas versus (81m)Kr ventilation-perfusion scintigraphy: a comparative study in patients with suspected acute pulmonary embolism.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(3):393-400.
2001: Hans-Martin Otten; Martin H Prins
A number needed to screen and cost-effectiveness analysis of the SOMIT-data.
Haemostasis 2001;31 Suppl 1():40-2.
2001: H M Otten; Martin H Prins
Venous thromboembolism and occult malignancy: an historical perspective.
Haemostasis 2001;31 Suppl 1():32-3.
2000: Ieneke J C Hartmann; Petronella J Hagen; CF Melissant; Pieter E Postmus; Martin H Prins
Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism.
American journal of respiratory and critical care medicine 2000;162(6):2232-7.
2000: AG van den Belt; Barbara A Hutten; Martin H Prins; P M Bossuy
Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S--a decision analysis.
Thrombosis and haemostasis 2000;84(5):758-63.
2000: Jeroen F van der Heijden; Martin H Prins; Harry R Büller
For the initial treatment of venous thromboembolism: are all low-molecular-weight heparin compounds the same?
Thrombosis research 2000;100(2):V121-30.
2000: Petronella J Hagen; Marco J L van Strijen; Gerard J Kieft; Martin H Prins; Pieter E Postmus
Availability of diagnostic facilities in the Netherlands for patients with suspected pulmonary embolism. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localisation of Pulmonary Embolism.
The Netherlands journal of medicine 2000;57(4):142-9.
2000: Barbara A Hutten; Martin H Prins; Michael Gent; J Ginsberg; Jan G P Tijssen; Harry R Büller
Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3078-83.
2000: ME Cromheecke; Marcel Levi; L P Colly; B J de Mol; Martin H Prins; B A Hutten; R Mak; K C Keyzers; Harry R Büller
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison.
Lancet 2000;356(9224):97-102.
2000: Guido Tans; Joyce Curvers; S Middeldorp; M Christella L G D Thomassen; Joost C M Meijers; Martin H Prins; Bonno N Bouma; Harry R Büller; Jan Rosing
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Thrombosis and haemostasis 2000;84(1):15-21.
2000: Joost C M Meijers; Saskia Middeldorp; Winnie L Tekelenburg; Abraham E van den Ende; Guido Tans; Martin H Prins; Jan Rosing; Harry R Büller; Bonno N Bouma
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Thrombosis and haemostasis 2000;84(1):9-14.
2000: Saskia Middeldorp; Joost C M Meijers; Abraham E van den Ende; A van Enk; Bonno N Bouma; Guido Tans; Jan Rosing; Martin H Prins; Harry R Büller
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Thrombosis and haemostasis 2000;84(1):4-8.
2000: Karel T Koch; Jan J Piek; Martin H Prins; Robbert J De Winter; Karla J Mulder; Kong I Lie; Jan G P Tijssen
Triage of patients for short term observation after elective coronary angioplasty.
Heart (British Cardiac Society) 2000;83(5):557-63.
2000: Bruno Girolami; Enrico Bernardi; Martin H Prins; JW Ten Cate; Paolo Prandoni; Paolo Simioni; Giuseppe Maria Andreozzi; Antonio Girolami; Harry R Büller
Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2000;19(4):370-80.
2000: Bernd-Jan Sanson; JG Lijmer; Melvin R Mac Gillavry; F Turkstra; Martin H Prins; Harry R Büller
Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism. ANTELOPE-Study Group.
Thrombosis and haemostasis 2000;83(2):199-203.
2000: Jeroen F van der Heijden; Martin H Prins; Harry R Büller
Low-molecular-weight heparins: are they interchangeable?
Haemostasis 2000;30 Suppl 2():148-57; discussion 146-7.
2000: Patrick Bossuyt; Martin H Prins
Does low-molecular-weight heparin reduce the costs of venous thromboembolism treatment?
Haemostasis 2000;30 Suppl 2():136-40; discussion 128-9.
2000: Hans-Martin Otten; Martin H Prins; Susanne M Smorenburg; Barbara A Hutten
Risk assessment and prophylaxis of venous thromboembolism in non-surgical patients: cancer as a risk factor.
Haemostasis 2000;30 Suppl 2():72-6; discussion 63.
2000: BA Hutten; Harry R Büller; Martin H Prins
Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Cochrane database of systematic reviews (Online) 2000;(4):CD002001.
2000: Roderik A Kraaijenhagen; P S in't Anker; Maria M W Koopman; Pieter H Reitsma; Martin H Prins; Abraham E van den Ende; Harry R Büller
High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism.
Thrombosis and haemostasis 2000;83(1):5-9.
1999: Jan Rosing; S Middeldorp; Joyce Curvers; M Christella; L G D Thomassen; Gerry A F Nicolaes; Joost C M Meijers; Bonno N Bouma; Harry R Büller; Martin H Prins; Guido Tans
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Lancet 1999;354(9195):2036-40.
1999: Marcel Levi; ME Cromheecke; Evert de Jonge; Martin H Prins; B J de Mol; E Briët; Harry R Büller
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.
Lancet 1999;354(9194):1940-7.
1999: Susanne M Smorenburg; Barbara A Hutten; Martin H Prins
Should patients with venous thromboembolism and cancer be treated differently?
Haemostasis 1999;29 Suppl S1():91-7.
1999: Bernd-Jan Sanson; Paolo Simioni; Daniela Tormene; M Moia; Philip W Friederich; Menno V Huisman; Paolo Prandoni; A Bura; L Rejto; P Wells; P M Mannucci; Antonio Girolami; Harry R Büller; Martin H Prins
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study.
Blood 1999;94(11):3702-6.
1999: Paolo Prandoni; Anthonie W A Lensing; Martin H Prins; Paola Bagatella; Alberta Scudeller; Antonio Girolami
Which is the outcome of the post-thrombotic syndrome?
Thrombosis and haemostasis 1999;82(4):1358.
1999: Barbara A Hutten; Martin H Prins; WK Redekop; Jan G P Tijssen; Siem H Heisterkamp; Harry R Büller
Comparison of three methods to assess therapeutic quality control of treatment with vitamin K antagonists.
Thrombosis and haemostasis 1999;82(4):1260-3.
1999: ME Wittekoek; Eric de Groot; Martin H Prins; Mieke D Trip; Harry R Büller; John J P Kastelein
Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease.
Atherosclerosis 1999;146(2):271-9.
1999: Jeroen G Lijmer; Ben W J Mol; Siem H Heisterkamp; Gouke J Bonsel; Martin H Prins; Jan van der Meulen; Patrick Bossuyt
Empirical evidence of design-related bias in studies of diagnostic tests.
JAMA : the journal of the American Medical Association 1999;282(11):1061-6.
1999: Nick R Bijsterveld; RJ Hettiarachchi; R Peters; Martin H Prins; Marcel Levi; Harry R Büller
Low-molecular weight heparins in venous and arterial thrombotic disease.
Thrombosis and haemostasis 1999;82 Suppl 1():139-47.
1999: Paolo Prandoni; Anthonie W A Lensing; Martin H Prins; Paola Bagatella; Alberta Scudeller; Antonio Girolami
Which is the outcome of the post-thrombotic syndrome?
Thrombosis and haemostasis 1999;82(3):1196-7.
1999: RJ Hettiarachchi; Susanne M Smorenburg; J Ginsberg; M Levine; Martin H Prins; Harry R Büller
Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread.
Thrombosis and haemostasis 1999;82(2):947-52.
1999: Martin H Prins; Barbara A Hutten; Maria M W Koopman; Harry R Büller
Long-term treatment of venous thromboembolic disease.
Thrombosis and haemostasis 1999;82(2):892-8.
1999: Marielle van Pampus; Maria M W Koopman; Hans Wolf; Harry R Büller; Martin H Prins; Abraham E van den Ende
Lipoprotein(a) concentrations in women with a history of severe preeclampsia--a case control study.
Thrombosis and haemostasis 1999;82(1):10-3.
1999: Johan R Meinardi; Saskia Middeldorp; Pieter J de Kam; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Increased risk for fetal loss in carriers of the factor V Leiden mutation.
Annals of internal medicine 1999;130(9):736-9.
1999: Bruno Girolami; Enrico Bernardi; Martin H Prins; JW Ten Cate; Paolo Prandoni; R Hettiarachchi; E Marras; Piero M Stefani; Antonio Girolami; Harry R Büller
Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
Thrombosis and haemostasis 1999;81(5):715-22.
1999: Bernd-Jan Sanson; Anthonie W A Lensing; Martin H Prins; J S Ginsberg; Z S Barkagan; E Lavenne-Pardonge; B Brenner; M Dulitzky; J D Nielsen; Z Boda; S Turi; Melvin R Mac Gillavry; Karly Hamulyák; I M Theunissen; B J Hunt; Harry R Büller
Safety of low-molecular-weight heparin in pregnancy: a systematic review.
Thrombosis and haemostasis 1999;81(5):668-72.
1999: Barbara A Hutten; Anthonie W A Lensing; Roderik A Kraaijenhagen; Martin H Prins
Safety of treatment with oral anticoagulants in the elderly. A systematic review.
Drugs & aging 1999;14(4):303-12.
1999: PM Kuijer; Barbara A Hutten; Martin H Prins; Harry R Büller
Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.
Archives of internal medicine 1999;159(5):457-60.
1999: F Turkstra; R Karemaker; PM Kuijer; Martin H Prins; Harry R Büller
Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
Thrombosis and haemostasis 1999;81(3):345-8.
1999: Bruno Girolami; Enrico Bernardi; Martin H Prins; JW Ten Cate; R Hettiarachchi; Paolo Prandoni; Antonio Girolami; Harry R Büller
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
Archives of internal medicine 1999;159(4):337-45.
1999: Anthonie W A Lensing; Paolo Prandoni; Martin H Prins; Harry R Büller
Deep-vein thrombosis.
Lancet 1999;353(9151):479-85.
1999: Paolo Simioni; Bernd-Jan Sanson; Paolo Prandoni; Daniela Tormene; Philip W Friederich; Bruno Girolami; Sabrina Gavasso; Menno V Huisman; Harry R Büller; J Wouter ten Cate; Antonio Girolami; Martin H Prins
Incidence of venous thromboembolism in families with inherited thrombophilia.
Thrombosis and haemostasis 1999;81(2):198-202.
1999: Rendrik F Franco; MD Trip; Hugo ten Cate; A van den Ende; Martin H Prins; JJ Kastelein; Pieter H Reitsma
The 20210 G-->A mutation in the 3'-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease.
British journal of haematology 1999;104(1):50-4.
1998: B J Verhoeff; MD Trip; Martin H Prins; JJ Kastelein; Pieter H Reitsma
The effect of a common methylenetetrahydrofolate reductase mutation on levels of homocysteine, folate, vitamin B12 and on the risk of premature atherosclerosis.
Atherosclerosis 1998;141(1):161-6.
1998: Rendrik F Franco; Marco Zago; MD Trip; Hugo ten Cate; A van den Ende; Martin H Prins; JJ Kastelein; Pieter H Reitsma
Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease.
British journal of haematology 1998;102(5):1172-5.
1998: RJ Hettiarachchi; Martin H Prins; Anthonie W A Lensing; Harry R Buller
Low molecular weight heparin versus unfractionated heparin in the initial treatment of venous thromboembolism.
Current opinion in pulmonary medicine 1998;4(4):220-5.
1998: Steven A J Chamuleau; Robbert J De Winter; Marcel Levi; R Adams; Harry R Büller; Martin H Prins; Kong I Lie; Ron J G Peters
Low molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study. Fraxiparin Anticoagulant Therapy in Myocardial Infarction Study Amsterdam (FATIMA) Study Group.
Heart (British Cardiac Society) 1998;80(1):35-9.
1998: RJ Hettiarachchi; J Lok; Martin H Prins; Harry R Büller; Paolo Prandoni
Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis.
Cancer 1998;83(1):180-5.
1998: AG van den Belt; Patrick Bossuyt; Martin H Prins; A S Gallus; Harry R Büller
Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
Thrombosis and haemostasis 1998;79(2):259-63.
1998: Patrick Bossuyt; AG van den Belt; Martin H Prins
Out-of-hospital treatment of venous thrombosis: socioeconomic aspects and patients' quality of life.
Haemostasis 1998;28 Suppl 3():100-7.
1998: Saskia Middeldorp; CM Henkens; Maria M W Koopman; Elisabeth C M van Pampus; Karly Hamulyák; Jan van der Meer; Martin H Prins; Harry R Büller
The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.
Annals of internal medicine 1998;128(1):15-20.
1997: AG van den Belt; Bernd-Jan Sanson; Paolo Simioni; Paolo Prandoni; Harry R Büller; Antonio Girolami; Martin H Prins
Recurrence of venous thromboembolism in patients with familial thrombophilia.
Archives of internal medicine 1997;157(19):2227-32.
1997: Y P Graafsma; Martin H Prins; Anthonie W A Lensing; R J de Haan; Menno V Huisman; Harry R Büller
Bleeding classification in clinical trials: observer variability and clinical relevance.
Thrombosis and haemostasis 1997;78(4):1189-92.
1997: Roderik A Kraaijenhagen; Anthonie W A Lensing; J G Lijmer; Paolo Prandoni; Martin H Prins; J S Ginsberg; Harry R Buller
Diagnostic strategies for the management of patients with clinically suspected deep-vein thrombosis.
Current opinion in pulmonary medicine 1997;3(4):268-74.
1997: Martin H Prins; RJ Hettiarachchi; Anthonie W A Lensing; J Hirsh
Newly diagnosed malignancy in patients with venous thromboembolism. Search or wait and see?
Thrombosis and haemostasis 1997;78(1):121-5.
1997: Paolo Simioni; Paolo Prandoni; Anthonie W A Lensing; Alberta Scudeller; Corrado Sardella; Martin H Prins; Sabina Villalta; F Dazzi; Antonio Girolami
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
The New England journal of medicine 1997;336(6):399-403.
1996: Philip W Friederich; Bernd-Jan Sanson; Paolo Simioni; S Zanardi; Menno V Huisman; I Kindt; Paolo Prandoni; Harry R Büller; Antonio Girolami; Martin H Prins
Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis.
Annals of internal medicine 1996;125(12):955-60.
1996: JW ten Cate; Martin H Prins
Major orthopaedic surgery and post-discharge DVT.
Lancet 1996;348(9022):209-10.
1996: Paolo Prandoni; Anthonie W A Lensing; A Cogo; S Cuppini; Sabina Villalta; M Carta; A M Cattelan; P Polistena; Enrico Bernardi; Martin H Prins
The long-term clinical course of acute deep venous thrombosis.
Annals of internal medicine 1996;125(1):1-7.
1996: H R Büller; M M Koopman; D P Brandjes; J van der Meer; Martin H Prins; J W ten Cate
[Deep venous thrombosis: does recently improved knowledge lead to a real advance in the direction patient care?].
Nederlands tijdschrift voor geneeskunde 1996;140(11):587-90.
1996: M M Koopman; Paolo Prandoni; Franco Piovella; P A Ockelford; D P Brandjes; J van der Meer; A S Gallus; G Simonneau; C H Chesterman; Martin H Prins
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
The New England journal of medicine 1996;334(11):682-7.
1996: Bernd-Jan Sanson; Philip W Friederich; Paolo Simioni; S Zanardi; M V Hilsman; Antonio Girolami; JW ten Cate; Martin H Prins
The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women.
Thrombosis and haemostasis 1996;75(3):387-8.
1995: W E Kok; Ron J G Peters; Martin H Prins; Jan J Piek; Karel T Koch; GK David; Cees A Visser
Contribution of age and intimal lesion morphology to coronary artery wall mechanics in coronary artery disease.
Clinical science (London, England : 1979) 1995;89(3):239-46.
1995: JW ten Cate; M M Koopman; Martin H Prins; H R Büller
Treatment of venous thromboembolism.
Thrombosis and haemostasis 1995;74(1):197-203.
1995: A W Lensing; Martin H Prins; B L Davidson; J Hirsh
Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis.
Archives of internal medicine 1995;155(6):601-7.
1995: Karin Fijnvandraat; B Derkx; Marjolein Peters; R Bijlmer; Augueste Sturk; Martin H Prins; Sander J H van Deventer; JW ten Cate
Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.
Thrombosis and haemostasis 1995;73(1):15-20.
1994: Martin H Prins; Anthonie W A Lensing; J Hirsh
Idiopathic deep venous thrombosis. Is a search for malignant disease justified?
Archives of internal medicine 1994;154(12):1310-2.
1992: Paolo Prandoni; Anthonie W A Lensing; Harry R Büller; A Cogo; Martin H Prins; A M Cattelan; S Cuppini; F Noventa; JW ten Cate
Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.
The New England journal of medicine 1992;327(16):1128-33.